ReproCELL Incorporated (TYO:4978)
137.00
0.00 (0.00%)
Sep 16, 2026, 3:30 PM JST
ReproCELL Employees
ReproCELL had 101 employees as of March 31, 2026. The number of employees increased by 2 or 2.02% compared to the previous year.
Employees
101
Change (1Y)
2
Growth (1Y)
2.02%
Revenue / Employee
22.81M JPY
Profits / Employee
-4.32M JPY
Market Cap
14.22B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 101 | 2 | 2.02% |
| Mar 31, 2025 | 99 | 3 | 3.13% |
| Mar 31, 2024 | 96 | 4 | 4.35% |
| Mar 31, 2023 | 92 | -6 | -6.12% |
| Mar 31, 2022 | 98 | -8 | -7.55% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| RaQualia Pharma | 85 |
| Carna Biosciences | 61 |
| AnGes | 56 |
| Immuno-Biological Laboratories | 54 |
| Stella Pharma | 47 |
| OncoTherapy Science | 46 |
| StemRIM | 45 |
| Nano Holdings | 23 |
ReproCELL News
- 4 weeks ago - ReproCELL Quarterly report: Q1 2027 - Filings
- 7 months ago - ReproCELL Quarterly report: Q3 2026 - Filings
- 10 months ago - ReproCELL Quarterly report: Q2 2026 - Filings